• Burford Capital Price Target Cut to $13.00 by Analysts at Wedbush

    7 days ago - By ETF Daily News

    Burford Capital had its price objective lowered by analysts at Wedbush from $14.00 to $13.00 in a research note issued on Thursday, Benzinga reports. The firm currently has an “outperform” rating on the stock. Wedbush's price target would suggest a potential upside of 92.59% from the stock's current price. Wedbush also...
    Read more ...

     

  • Mind Medicine Stock Rating Reaffirmed by HC Wainwright

    8 days ago - By ETF Daily News

    Mind Medicine ‘s stock had its “buy” rating reiterated by analysts at HC Wainwright in a research note issued on Thursday, Benzinga reports. They currently have a $75.00 price target on the stock. HC Wainwright also issued estimates for Mind Medicine 's FY2027 earnings at $0.14 EPS. A number of other...
    Read more ...

     

  • Stifel Nicolaus Raises CIRCOR International Price Target to $40.00

    8 days ago - By ETF Daily News

    CIRCOR International had its price target upped by analysts at Stifel Nicolaus from $30.00 to $40.00 in a research report issued on Thursday, Benzinga reports. The firm currently has a “buy” rating on the industrial products company's stock. Stifel Nicolaus' target price suggests a potential upside of 35.92% from the stock's...
    Read more ...

     

  • Cadre PT Lowered to $25.00

    8 days ago - By ETF Daily News

    Cadre had its price objective reduced by stock analysts at Stifel Nicolaus from $28.00 to $25.00 in a report released on Thursday, Benzinga reports. The brokerage currently has a “hold” rating on the stock. Stifel Nicolaus' price target would indicate a potential upside of 31.44% from the stock's previous close. Other...
    Read more ...

     

  • Stifel Nicolaus Raises Insight Enterprises Price Target to $150.00

    8 days ago - By ETF Daily News

    Insight Enterprises had its price target increased by stock analysts at Stifel Nicolaus from $135.00 to $150.00 in a research note issued on Thursday, Benzinga reports. The brokerage currently has a “buy” rating on the software maker's stock. Stifel Nicolaus' price target indicates a potential upside of 8.69% from the company's...
    Read more ...

     

  • Brilliant Earth Group PT Lowered to $5.00

    8 days ago - By ETF Daily News

    Brilliant Earth Group had its price target decreased by stock analysts at JPMorgan Chase & Co. from $6.00 to $5.00 in a research report issued on Thursday, Benzinga reports. The brokerage currently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s price target would indicate a potential upside of...
    Read more ...

     

  • JPMorgan Chase & Co. Trims Five Below Target Price to $237.00

    8 days ago - By ETF Daily News

    Five Below had its target price dropped by equities researchers at JPMorgan Chase & Co. from $239.00 to $237.00 in a research report issued on Thursday, Benzinga reports. The firm currently has an “overweight” rating on the specialty retailer's stock. JPMorgan Chase & Co.‘s price objective indicates a potential upside of...
    Read more ...

     

  • Enlight Renewable Energy PT Lowered to $22.00

    8 days ago - By ETF Daily News

    Enlight Renewable Energy had its price objective lowered by equities researchers at JPMorgan Chase & Co. from $23.00 to $22.00 in a research report issued on Thursday, Benzinga reports. The brokerage currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s target price indicates a potential upside of 35.38%...
    Read more ...

     

  • JPMorgan Chase & Co. Lowers iTeos Therapeutics Price Target to $32.00

    8 days ago - By ETF Daily News

    ITeos Therapeutics had its price objective lowered by analysts at JPMorgan Chase & Co. from $34.00 to $32.00 in a note issued to investors on Thursday, Benzinga reports. The brokerage currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s target price would suggest a potential upside of 126.63%...
    Read more ...

     

  • Sportradar Group Price Target Lowered to $14.00 at JPMorgan Chase & Co

    8 days ago - By ETF Daily News

    Sportradar Group had its price objective cut by analysts at JPMorgan Chase & Co. from $15.00 to $14.00 in a research report issued on Thursday, Benzinga reports. The firm currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price objective would indicate a potential upside of 36.05% from...
    Read more ...